Health ❯ Healthcare ❯ Public Health ❯ Disease Prevention

Vaccination Programs

Pfizer, Valneva Seek Approval for Lyme Vaccine After >70% Efficacy in Phase 3

Regulators will judge strong efficacy against limited case counts.

Robot Vacuum Discounts Surge With Record and Near‑Record Lows Across Major Retailers

RHOC Turmoil Deepens as Tamra Judge Quits Again at Her Own Party

AstraZeneca Launches FluMist Home Direct-to-Consumer Nasal Vaccine in 34 States

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women